FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948667515> ?p ?o ?g. }

• W2948667515 abstract "Abstract Bisphosphonates are frequently used for the antiresorptive treatment in bone metastasis diseases or for osteoporosis. A side effect of this therapy is osteonecrosis of the jaw. This inhibits osteoclast function, but osteoblasts and fibroblasts are also negatively affected in terms of impaired proliferation. Additive local treatment with platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) promotes adhesion, proliferation and migration of cells due to high concentrations of growth factors like PDGF, TGF and IGF. The aim of the study was to investigate the effect of PRP or PRF on proliferation, migration and viability of osteoblasts and oral fibroblasts, treated with zoledronic acid (ZA). ZA treated fibroblasts and osteoblasts were exposed to PRP/PRF. Cell proliferation, migration and viability were measured using the real-time cell-analyzer assay (RTCA), the scratch assay and the MTT assay. There was a significant increase in closure of the scratch area by PRP/PRF treated osteoblasts (PRP = 40.6%, PRF = 100.0%, NC = 0.0%) as well as fibroblasts (PRP = 100.0%, PRF = 100.0%, NC = 12.7%) in comparison to the group of negative control (all p ≤ 0 . 05 ). Furthermore, the negative effect of ZA on cell migration was generally reduced in both cell lines using PRP/PRF. The viability and proliferation of cells decreased after exposure to ZA, whereas we observed an enhancement of cell viability within 24 hours by application of PRP/PRF in ZA treated cells. The negative effect of ZA on cell proliferation was especially reduced when using PRF. The use of PRF/PRP improves the behavior of ZA-treated cells, but PRF appears to have an advantage in comparison to PRP. This study demonstrates that treatment with PRF/PRP may have positive effects in the therapy of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)." @default.
• W2948667515 created "2019-06-14" @default.
• W2948667515 creator A5015097699 @default.
• W2948667515 creator A5016951596 @default.
• W2948667515 creator A5034062838 @default.
• W2948667515 creator A5036167305 @default.
• W2948667515 creator A5062607071 @default.
• W2948667515 date "2019-06-05" @default.
• W2948667515 modified "2023-10-01" @default.
• W2948667515 title "Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid" @default.
• W2948667515 cites W1968526774 @default.
• W2948667515 cites W1976852589 @default.
• W2948667515 cites W1977240105 @default.
• W2948667515 cites W1977778661 @default.
• W2948667515 cites W1981220199 @default.
• W2948667515 cites W1982182518 @default.
• W2948667515 cites W1998912363 @default.
• W2948667515 cites W2001519266 @default.
• W2948667515 cites W2004918964 @default.
• W2948667515 cites W2006061245 @default.
• W2948667515 cites W2006569561 @default.
• W2948667515 cites W2015625211 @default.
• W2948667515 cites W2019158219 @default.
• W2948667515 cites W2020832712 @default.
• W2948667515 cites W2022450902 @default.
• W2948667515 cites W2027621720 @default.
• W2948667515 cites W2035426304 @default.
• W2948667515 cites W2038826745 @default.
• W2948667515 cites W2039701074 @default.
• W2948667515 cites W2060940729 @default.
• W2948667515 cites W2062366350 @default.
• W2948667515 cites W2064563396 @default.
• W2948667515 cites W2075540043 @default.
• W2948667515 cites W2075544617 @default.
• W2948667515 cites W2076769374 @default.
• W2948667515 cites W2077073060 @default.
• W2948667515 cites W2082168107 @default.
• W2948667515 cites W2086838304 @default.
• W2948667515 cites W2090064140 @default.
• W2948667515 cites W2097492875 @default.
• W2948667515 cites W2101582557 @default.
• W2948667515 cites W2133600872 @default.
• W2948667515 cites W2137302084 @default.
• W2948667515 cites W2141651735 @default.
• W2948667515 cites W2143887475 @default.
• W2948667515 cites W2154867093 @default.
• W2948667515 cites W2160102488 @default.
• W2948667515 cites W2168789685 @default.
• W2948667515 cites W2171601824 @default.
• W2948667515 cites W2212021998 @default.
• W2948667515 cites W2212543853 @default.
• W2948667515 cites W2221993315 @default.
• W2948667515 cites W2252857368 @default.
• W2948667515 cites W2301893039 @default.
• W2948667515 cites W2490222838 @default.
• W2948667515 cites W2511384942 @default.
• W2948667515 cites W2564465301 @default.
• W2948667515 cites W2586976098 @default.
• W2948667515 cites W2586979463 @default.
• W2948667515 cites W2603302878 @default.
• W2948667515 cites W2620914894 @default.
• W2948667515 cites W2789931768 @default.
• W2948667515 cites W2791031405 @default.
• W2948667515 cites W2887148599 @default.
• W2948667515 cites W2892321210 @default.
• W2948667515 cites W2901956519 @default.
• W2948667515 cites W2913186396 @default.
• W2948667515 cites W4239901602 @default.
• W2948667515 cites W4319688072 @default.
• W2948667515 doi "https://doi.org/10.1038/s41598-019-43798-z" @default.
• W2948667515 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6549154" @default.
• W2948667515 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31165745" @default.
• W2948667515 hasPublicationYear "2019" @default.
• W2948667515 type Work @default.
• W2948667515 sameAs 2948667515 @default.
• W2948667515 citedByCount "33" @default.
• W2948667515 countsByYear W29486675152019 @default.
• W2948667515 countsByYear W29486675152020 @default.
• W2948667515 countsByYear W29486675152021 @default.
• W2948667515 countsByYear W29486675152022 @default.
• W2948667515 countsByYear W29486675152023 @default.
• W2948667515 crossrefType "journal-article" @default.
• W2948667515 hasAuthorship W2948667515A5015097699 @default.
• W2948667515 hasAuthorship W2948667515A5016951596 @default.
• W2948667515 hasAuthorship W2948667515A5034062838 @default.
• W2948667515 hasAuthorship W2948667515A5036167305 @default.
• W2948667515 hasAuthorship W2948667515A5062607071 @default.
• W2948667515 hasBestOaLocation W29486675151 @default.
• W2948667515 hasConcept C126322002 @default.
• W2948667515 hasConcept C137738243 @default.
• W2948667515 hasConcept C1491633281 @default.
• W2948667515 hasConcept C153911025 @default.
• W2948667515 hasConcept C16685009 @default.
• W2948667515 hasConcept C185592680 @default.
• W2948667515 hasConcept C202751555 @default.
• W2948667515 hasConcept C203014093 @default.
• W2948667515 hasConcept C2776033226 @default.
• W2948667515 hasConcept C2776326535 @default.
• W2948667515 hasConcept C2776541429 @default.
• W2948667515 hasConcept C2777251235 @default.

• next